Salvage Therapy With Polatuzumab Vedotin, Bendamustine, and Rituximab Prior to Allogeneic Hematopoietic Transplantation in Patients With Aggressive Lymphomas Relapsing After Therapy With Chimeric Antigen Receptor T-Cells—Report on Two Cases

Kristin Gerhardt, Vladan Vučinić(University Hospital Leipzig), Osama Sabri(Klinik und Poliklinik für Nuklearmedizin), Enrica Bach, Aleksandra Sretenović(University of Belgrade), Madlen Jentzsch, Astrid Monecke(Leipzig University), Sabine Leiblein, Milena Todorović(University of Belgrade), Thomas Georgi(Leipzig University), Uwe Platzbecker(National Center for Tumor Diseases), Jelena Bila(University of Belgrade), Michael Cross(Leeds Teaching Hospitals NHS Trust), Sandra Hoffmann(Economic Research Service), Georg‐Nikolaus Franke(University Hospital Leipzig), Sebastian Schwind
Frontiers in Oncology
September 16, 2021
Cited by 6


Related Papers